Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula

Autor: Giovanni Pertosa, Giuseppe Grandaliano, Daniela Marrone, Antonia Loverre, Giuseppe Castellano, Giuseppe Dalfino, Angela Di Vittorio, Simona Simone, Francesco Paolo Schena
Předmět:
Male
Pathology
medicine.medical_treatment
Endothelial cells
Messenger
Complement Membrane Attack Complex
Constriction
Pathologic

Pentraxin 3
Pathogenesis
Kidney Failure
Smooth Muscle
Leukocytes
Settore MED/14 - NEFROLOGIA
Treatment Failure
Chronic
Complement Activation
Arterovenous fistula
Arteriovenous malformation
PTX3
Middle Aged
Constriction
Serum Amyloid P-Component
C-Reactive Protein
Female
Hemodialysis
Cardiology and Cardiovascular Medicine
Adult
congenital
hereditary
and neonatal diseases and abnormalities

medicine.medical_specialty
Mononuclear
Myocytes
Smooth Muscle

Complement
Arteriovenous fistula
End stage renal disease
Emodialysis
Renal Dialysis
Vascular
medicine
Humans
cardiovascular diseases
Endothelium
RNA
Messenger

Aged
Pathologic
Myocytes
business.industry
Vascular disease
Arteriovenous Anastomosis
medicine.disease
Stenosis
Leukocytes
Mononuclear

RNA
Kidney Failure
Chronic

Endothelium
Vascular

business
Biomarkers
Zdroj: Università degli studi di Foggia-IRIS
Università degli Studi di Milano-IRIS
Popis: Objective Pentraxin-3 (PTX3) has been suggested to play a role in the development of vascular pathology. Stenosis of arteriovenous fistula (AVF) leading to its failure is the major cause of morbidity in hemodialysis patients. To date, little is known on the pathogenesis of AVF stenosis. The aim of the present study was to investigate the potential role of PTX3 in this setting. Methods and results A sample of venous wall was collected at the time of AVF formation in 44 patients with end stage renal disease. Ten patients developed AVF stenosis and from these patients a second portion of the venous wall was obtained during surgical revision of the AVF. Confocal laser scanning microscopy demonstrated that PTX3 immunostaining, hardly detectable in native AVF, was significantly increased in failed AVF, showing a specific co-localization with endothelial cell markers. Circulating mononuclear cells isolated at the time of AVF revision presented a significantly higher PTX3 mRNA expression than those collected during AVF creation. Interestingly, a significant deposition of C5b-9 on endothelial cells, co-localizing with PTX3, was observed in stenotic AVF. Conclusion The present study demonstrates for the first time a close association between PTX3 deposition and complement activation at the endothelial cell level in failed AVF and suggests a role for PTX3 in modulating innate immunity in the pathogenesis of AVF stenosis.
Databáze: OpenAIRE